Data Loading...
Office_Resource_Guide Flipbook PDF
Office_Resource_Guide
101 Views
70 Downloads
FLIP PDF 1.72MB
B:6.25” T:6”
HELP YOUR PATIENTS GET EPIDUO FORTE (adapalene and benzoyl peroxide) 0.3%/2.5% GEL— ®
THE #1 PRESCRIBED BRANDED TOPICAL ACNE TREATMENT1
When you prescribe Epiduo Forte Gel, the Galderma® CareConnect Patient Savings Program* is remarkably simple
Give the Patient Savings Card*† to all commercial patients For up to a 3-month supply of Epiduo Forte Gel:
• COMMERCIALLY UNRESTRICTED PATIENTS PAY $O • UNINSURED PAYMENT IS $75
• N O ACTIVATION is required and the Patient Savings Card can be used at any pharmacy • If Prior Authorization is denied, use the program’s cash option—$75
Download a card at GaldermaCC.com
To ensure patients receive Epiduo Forte Gel: • CHECK “Dispense As Written” (there is no generic substitute for Epiduo Forte Gel) • INCLUDE ICD-10 codes and previous treatment failures in notes to pharmacist • R EMEMBER to save as a favorite in the EMR system to ensure the process is easier in the future
Important Safety Information Indication: Epiduo Forte (adapalene and benzoyl peroxide) Gel, 0.3%/2.5% is indicated for the topical treatment of acne vulgaris. Adverse Events: In the pivotal study, the most commonly reported adverse reactions (≥1%) in patients treated with Epiduo Forte Gel were skin irritation, eczema, atopic dermatitis, and skin burning sensation. Warnings/Precautions: Patients using Epiduo Forte Gel should avoid exposure to sunlight and sunlamps and wear sunscreen when sun exposure cannot be avoided. Erythema, scaling, dryness, stinging/burning, irritant and allergic contact dermatitis may occur with use of Epiduo Forte Gel and may necessitate discontinuation. When applying Epiduo Forte Gel, care should be taken to avoid the eyes, lips and mucous membranes. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/Safety/MedWatch or call 1-800-FDA-1088. Please see full Prescribing Information at www.epiduoforte.com. *Galderma CareConnect is only available for commercially insured or uninsured patients. Patients who are enrolled in a government-run or government-sponsored healthcare plan with a pharmacy benefit are not eligible to use the Galderma CareConnect Patient Savings Card. † Restrictions apply. Please see Galderma CareConnect Patient Savings Card for details. Reference: 1. Symphony Health, Pharmaceutical Audit Suite. Prescription Monthly. August 2015 to June 2017.
www.epiduoforte.com/hcp All trademarks are the property of their respective owners. ©2017 Galderma Laboratories, L.P. Galderma Laboratories, L.P. 14501 N. Freeway Fort Worth, TX 76177 EFO/0108/0617 Printed in USA 07/17
10793435_EPI_FORTE_SCRIPT_LOSS_LB_M5.indd 1
7/12/17 2:38 PM
B:10.25”
T:10”
• REMIND patients to use the Epi-Forte Tracker mobile app for convenient access